Mastura Monif

Projects

Projects per year 2018 2020 2021 2022 2023 2024 2030

• 10 Active
• 14 Finished

Projects per year

Search results

• Active

  The ACRF Centre for Dynamic Immuno-Oncology (CDIO)

  Shackleton, M. (Primary Chief Investigator (PCI)), Cherk, M. (Chief Investigator (CI)), Naranbhai, V. (Chief Investigator (CI)), McLean, C. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)), Si Lun Tam, C. (Chief Investigator (CI)), Kalff, A. (Chief Investigator (CI)), Fleming, S. (Chief Investigator (CI)), Mar, V. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)) & Cheung, J. (Project Manager)

  7/04/25 → 7/01/30

  Project: Research

• Electroencephalogram (EEG) in autoimmune encephalitis diagnosis and prognosis.

  Tan, T. (Primary Chief Investigator (PCI)), Monif, M. (Associate Investigator (AI)), Wesselingh, R. (Associate Investigator (AI)), Seery, N. (Associate Investigator (AI)), Kwan, P. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  1/01/25 → 1/01/26

  Project: Research

• An open-label, multi-center, phase I/II study to assess safety, disease progression, and cellular kinetics following YTB323 administration in participants with non-active Progressive Multiple Sclerosis (PMS)

  Monif, M. (Primary Chief Investigator (PCI))

  18/11/24 → 2/05/28

  Project: Research

• An open-label, multi-center, phase 1/2 study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with Relapsing Multiple Sclerosis with breakthrough disease activity during previous treatment with a highly efficacious therapy

  Monif, M. (Primary Chief Investigator (PCI))

  1/10/24 → 30/09/26

  Project: Research

• CureMOG: A randomised double-blind placebo-controlled multicentre phase III clinical trial for the treatment of MOGAD

  Ramanathan, S. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), Brown, D. A. (Chief Investigator (CI)), Van Der Walt, A. (Chief Investigator (CI)), Kalincik, T. (Chief Investigator (CI)), Miteff, C. (Associate Investigator (AI)), Fraser, C. (Associate Investigator (AI)), Klistorner, A. (Associate Investigator (AI)), Hardy, T. A. (Associate Investigator (AI)), Barnett, M. H. (Chief Investigator (CI)), Broadley, S. (Chief Investigator (CI)), Spelman, T. D. (Chief Investigator (CI)), Lindley, R. I. (Chief Investigator (CI)), Brilot-Turville, F. (Chief Investigator (CI)), Dale, R. C. (Chief Investigator (CI)), Slee, M. (Chief Investigator (CI)), Lewfelar, J. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Lechner-Scott, J. (Chief Investigator (CI)), Monif, M. (Associate Investigator (AI)) & George, S. (Associate Investigator (AI))

  1/06/24 → 31/05/29

  Project: Research

• Australian Autoimmune Encephalitis Consortium Study - improving diagnosis, outcomes, and quality of care for patients with this devastating neurological illness.

  Monif, M. (Primary Chief Investigator (PCI)), Wesselingh, R. (Chief Investigator (CI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Haartsen, J. (Chief Investigator (CI)), Hardy, T. A. (Chief Investigator (CI)), Gillis, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Blum, S. (Chief Investigator (CI)), Nesbitt, C. S. (Chief Investigator (CI)), Heiss, L. (Chief Investigator (CI)), Macdonell, R. A. L. (Chief Investigator (CI)), Mykytowycz, M. (Chief Investigator (CI)), Sanfilippo, P. (Chief Investigator (CI)), D'Souza, W. J. (Associate Investigator (AI)), Kulkarni, J. (Associate Investigator (AI)), Buzzard, K. (Associate Investigator (AI)), O'Brien, T. (Associate Investigator (AI)), Broadley, S. (Associate Investigator (AI)), Taylor, B. V. (Associate Investigator (AI)), MacIntyre, J. (Associate Investigator (AI)), Barton, J. (Associate Investigator (AI)), Swayne, A. (Associate Investigator (AI)), Alpitsis, R. (Associate Investigator (AI)), Harding, I. (Associate Investigator (AI)), Butler, E. (Associate Investigator (AI)), Ramanathan, S. (Associate Investigator (AI)), Giles, A. (Associate Investigator (AI)) & Gadi, M. (Associate Investigator (AI))

  1/03/24 → 31/12/27

  Project: Research

• Fatigue In Relapsing Multiple Sclerosis Epstein Barr Virus (EBV) treatment trial (FIRMS-EBV)

  Hardy, T. A. (Primary Chief Investigator (PCI)), Giovannoni, G. (Chief Investigator (CI)), Kilpatrick, T. J. (Chief Investigator (CI)), Potter, A. (Chief Investigator (CI)), Gaudieri, S. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)), Parratt, J. D. E. (Chief Investigator (CI)), Bruestle, A. (Chief Investigator (CI)), Barton, J. (Chief Investigator (CI)), Lloyd, A. R. (Chief Investigator (CI)), Phan, T. (Chief Investigator (CI)), Vucic, O. (Chief Investigator (CI)), Ponsonby, A. L. (Chief Investigator (CI)) & Butzkueven, H. (Chief Investigator (CI))

  1/07/23 → 30/06/28

  Project: Research

• Targeting sphingolipid metabolism to combat the development of chronic fatigue syndrome.

  Xiao, J. (Primary Chief Investigator (PCI)), Orian, J. M. (Chief Investigator (CI)) & Monif, M. (Chief Investigator (CI))

  1/04/23 → 1/04/26

  Project: Research

• A randomized, double-blind, placebo- controlled, multicenter, Phase 3, PIVOTAL study with an open-label Extension period to evaluate the efficacy and safety of rozanolixizumab in adult participants with Myelin oligodendrocyte glycoprotein (MOG) ANTIBODY-ASSOCIATED disease (MOG-AD).

  Monif, M. (Primary Chief Investigator (PCI))

  13/05/22 → 31/12/26

  Project: Research

• Glioblastoma - inhibition of P2X7R as a potential therapeutic target for treatment of this aggressive cancer.

  Monif, M. (Primary Chief Investigator (PCI)), Hunn, M. (Chief Investigator (CI)), Drummond, K. J. (Associate Investigator (AI)), McLean, C. (Associate Investigator (AI)), Jones, N. (Associate Investigator (AI)), Sanfilippo, P. (Associate Investigator (AI)) & O'Brien, T. (Associate Investigator (AI))

  1/01/22 → 31/12/25

  Project: Research

• Finished

  Molecular biomarkers of autoimmune encephalitis.

  Wesselingh, R. (Primary Chief Investigator (PCI)), Monif, M. (Chief Investigator (CI)), Griffith, S. P. (Chief Investigator (CI)) & Seery, N. (Chief Investigator (CI))

  1/01/24 → 31/12/24

  Project: Research

• Development of PET tracers to track MS disease activity and progression

  Haskali, M. (Primary Chief Investigator (PCI)), Monif, M. (Chief Investigator (CI)), Vivash, L. (Chief Investigator (CI)), Jupp, B. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  1/08/23 → 31/07/24

  Project: Research

• The contribution of monocytes and P2X7 Receptor in Multiple Sclerosis relapse.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)) & Stankovich, J. (Chief Investigator (CI))

  2/02/22 → 31/12/23

  Project: Research

• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH LEUCINE-RICH GLIOMA INACTIVATED 1 AUTOIMMUNE ENCEPHALITIS

  Monif, M. (Primary Chief Investigator (PCI))

  24/08/21 → 31/12/24

  Project: Research

• The role of monocytes and P2X7 Receptor in the pathogenesis of relapsing remitting multiple sclerosis flare: a translational study.

  Monif, M. (Primary Chief Investigator (PCI)) & Butzkueven, H. (Chief Investigator (CI))

  Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited)

  18/03/21 → 31/12/23

  Project: Research

• The contribution of monocytes and P2X7 Receptor in Multiple Sclerosis relapse.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)) & Stankovich, J. (Chief Investigator (CI))

  2/03/21 → 31/12/21

  Project: Research

• Immune phenotyping and Disease modifying treatments in MS – implications for treatment response and infection.

  Van Der Walt, A. (Primary Chief Investigator (PCI)), Monif, M. (Chief Investigator (CI)) & Butzkueven, H. (Chief Investigator (CI))

  1/01/21 → 31/12/21

  Project: Research

• MAGPIX

  Monif, M. (Primary Chief Investigator (PCI)), Hibbs, M. (Chief Investigator (CI)), Tarlinton, D. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  1/01/21 → 31/12/21

  Project: Research

• Polarization of immune cells by novel compounds

  Ali, I. (Primary Chief Investigator (PCI)), Jones, N. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)) & Semple, B. (Chief Investigator (CI))

  Katholieke Universiteit Leuven (KU Leuven) (Catholic University of Leuven)

  13/07/20 → 12/09/21

  Project: Research

• Autoimmune Encephalitis - a rare and debilitating neurological illness affecting the Australian population. A study of the Australian Autoimmune Encephalitis Consortium.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Kalincik, T. (Chief Investigator (CI)), Tarlinton, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Kulkarni, J. (Chief Investigator (CI)), Buzzard, K. (Chief Investigator (CI)) & Taylor, B. V. (Chief Investigator (CI))

  1/06/20 → 31/05/25

  Project: Research

• The therapeutic role of P2X7 Receptor antagonism in human brain tumours

  Monif, M. (Primary Chief Investigator (PCI))

  1/01/20 → 2/02/21

  Project: Research

• CLADIN sub study. Effect of CLADribine on Innate Immune Response (CLADIN). MS Immunity Project.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  27/06/19 → 9/09/22

  Project: Research

• The role of microglia and P2X7 Receptor in human gliomas – a translational study

  Monif, M. (Primary Chief Investigator (PCI)), Drummond, K. J. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)), Williams, D. A. (Chief Investigator (CI)) & Kan, K. (Chief Investigator (CI))

  Brain Foundation

  1/01/19 → 31/12/19

  Project: Research

• PhD Project: Altered Vitamin D responsiveness in Multiple Sclerosis Immune Cells.

  Butzkueven, H. (Chief Investigator (CI)), Van Der Walt, A. (Primary Chief Investigator (PCI)), Stankovich, J. (Chief Investigator (CI)), Jokubaitis, V. (Chief Investigator (CI)) & Monif, M. (Chief Investigator (CI))

  Roche Products Pty Ltd (trading as Roche Australia)

  16/10/18 → 1/01/20

  Project: Research